Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioAge Labs, Inc. - Common Stock
(NQ:
BIOA
)
9.040
-15.810 (-63.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioAge Labs, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into BioAge Labs Inc For Securities Fraud
December 15, 2024
Via
ACCESSWIRE
Did BioAge Labs, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - BIOA
December 15, 2024
Via
ACCESSWIRE
ATTENTION BioAge Labs, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
December 15, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. (BIOA) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
December 14, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation
December 14, 2024
Via
ACCESSWIRE
An Investigation Has Commenced on Behalf of BioAge Labs, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your BIOA Losses.
December 13, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - BIOA
December 13, 2024
Via
ACCESSWIRE
Investors With Losses Are Invited To Join The Schall Law Firm's Inquiry Into BioAge Labs Inc For Securities Fraud
December 13, 2024
Via
ACCESSWIRE
Levi & Korsinsky Reminds Shareholders of an Investigation into BioAge Labs, Inc. (BIOA) Regarding Potential Securities Fraud Allegations
December 13, 2024
Via
ACCESSWIRE
Shareholders that lost money on BioAge Labs, Inc. (BIOA) should contact Levi & Korsinsky about Securities Fraud Investigation - BIOA
December 13, 2024
Via
ACCESSWIRE
Investors who lost money on BioAge Labs, Inc. should contact Levi & Korsinsky about an ongoing investigation - BIOA
December 12, 2024
Via
ACCESSWIRE
ATTENTION BIOA SHAREHOLDERS: Investors who lost money on BioAge Labs, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
December 12, 2024
Via
ACCESSWIRE
BioAge Labs Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Encourages Shareholder Participation
December 12, 2024
Via
ACCESSWIRE
Levi & Korsinsky Reminds Shareholders of an Investigation into BioAge Labs, Inc. (BIOA) Regarding Potential Securities Fraud Allegations
December 12, 2024
Via
ACCESSWIRE
BioAge Labs, Inc. Being Investigated on Behalf of BioAge Labs, Inc. Investors. Contact Levi & Korsinsky For Details
December 12, 2024
Via
ACCESSWIRE
Levi & Korsinsky Announces an Investigation on Behalf of BioAge Labs, Inc. (BIOA) Shareholders Who May Have Been Affected by Fraud
December 12, 2024
Via
ACCESSWIRE
BIOA Investors Have Opportunity to Join BioAge Labs, Inc. Securities Fraud Investigation with the Schall Law Firm
December 10, 2024
From
The Schall Law Firm
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 09, 2024
Via
Benzinga
Crude Oil Gains 2%; BioAge Labs Shares Plunge
↗
December 09, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; US Wholesale Inventories Rise By 0.2%
↗
December 09, 2024
Via
Benzinga
Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday
↗
December 09, 2024
Via
Benzinga
BioAge Labs, Riot Platforms And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
December 09, 2024
Via
Benzinga
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
↗
December 09, 2024
BioAge Labs halts STRIDES Phase 2 trial of azelaprag after liver enzyme elevations, plans further analysis with updates expected in Q1 2025.
Via
Benzinga
Topics
Initial Public Offering
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
↗
December 09, 2024
Via
Benzinga
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity
December 06, 2024
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst Clinic
December 05, 2024
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs to Present at Upcoming Investor Conferences
November 21, 2024
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 07, 2024
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
November 04, 2024
Two presentations to highlight increased weight loss in obese mice treated with azelaprag in combination with multiple oral appetite suppressants, and significant protection against weight gain with...
From
BioAge Labs, Inc.
Via
GlobeNewswire
BioAge Labs to Present at Jefferies London Healthcare Conference
October 24, 2024
From
BioAge Labs, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
